Harvest Technologies Corp.

Fears of blood supply contamination and the potential for blood typing errors, as well as the considerable costs associated with whole blood transfusions, have triggered efforts to reduce the need for surgical transfusions of banked (allogeneic) blood. One technology developed for this purpose is autotransfusion, which involves salvaging a patient's own (autologous) blood during surgery and processing it for reinfusion. Harvest Technologies Corp. is building upon the autotransfusion concept to create devices which not only have the capacity to collect a patient's blood just prior to and during surgery for subsequent transfusion, but can also convert collected blood into autologous blood products that promote post-surgical wound healing, bone growth and hemostasis.

Harvest Technologies began with one thing that device start-ups in today's desert of venture funding are hard-pressed to find: money....